Swiss Re AG (SSREY)
| Market Cap | 46.60B -11.6% |
| Revenue (ttm) | 42.39B -3.3% |
| Net Income | 4.86B +45.8% |
| EPS | 16.34 +44.2% |
| Shares Out | n/a |
| PE Ratio | 9.60 |
| Forward PE | 10.26 |
| Dividend | 1.27 (3.21%) |
| Ex-Dividend Date | Apr 15, 2026 |
| Volume | 3,003 |
| Average Volume | 54,797 |
| Open | 39.67 |
| Previous Close | 39.51 |
| Day's Range | 39.67 - 40.13 |
| 52-Week Range | 38.10 - 48.62 |
| Beta | 0.37 |
| RSI | 45.79 |
| Earnings Date | May 7, 2026 |
About Swiss Re AG
Swiss Re AG, together with its subsidiaries, provides wholesale reinsurance, insurance, other insurance-based forms of risk transfer, and other insurance-related services worldwide. The company operates through Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions. The Property & Casualty Reinsurance segment underwrites property reinsurance, including property, credit and surety, engineering, aviation, marine, agriculture, retakaful, and facultative reinsurance solutions; and casualty reinsurance, such as liability... [Read more]
Financial Performance
In 2025, Swiss Re AG's revenue was $42.60 billion, a decrease of -4.17% compared to the previous year's $44.45 billion. Earnings were $4.62 billion, an increase of 45.20%.
Financial StatementsNews
Swiss Re price target lowered to CHF 115 from CHF 118 at Morgan Stanley
Morgan Stanley analyst Hadley Cohen lowered the firm’s price target on Swiss Re (SSREY) to CHF 115 from CHF 118 and keeps an Underweight rating on the shares. Published first…
Swiss Re price target lowered to CHF 132 from CHF 137.64 at Citi
Citi analyst James Shuck lowered the firm’s price target on Swiss Re (SSREY) to CHF 132 from CHF 137.64 and keeps a Neutral rating on the shares. Published first on…
Swiss Re price target lowered to CHF 110 from CHF 118 at RBC Capital
RBC Capital lowered the firm’s price target on Swiss Re (SSREY) to CHF 110 from CHF 118 and keeps an Underperform rating on the shares.
Swiss Re AG Earnings Call Transcript: Q1 2026
Q1 2026 net income reached $1.5 billion with a 24% ROE, driven by strong underwriting and investment gains. P&C Re and Corporate Solutions delivered robust combined ratios, while Life & Health Re showed improved earnings and positive experience variance.
Swiss Re AG Slides: Q1 2026
Swiss Re AG has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
Swiss Re AG Earnings release: Q1 2026
Swiss Re AG released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
Swiss Re Net Profit Gets Boost From Lower Natural-Catastrophe Losses
The reinsurer said its property-and-casualty segment benefited from low large losses and its life-and-health segment from favorable U.S. mortality trends.
Swiss Re Q1 Profit Climbs, Insurance Revenue Drops
(RTTNews) - Reinsurer Swiss Re Ltd. (SSREY.PK) reported Thursday higher profit in its first quarter, despite weak insurance revenues. The company attributed the profit growth to increased contribution...
Swiss Re AG (XSWX:SREN) Q1 2026: Everything You Need to Know Ahead of Earnings
Swiss Re AG (XSWX:SREN) Q1 2026: Everything You Need to Know Ahead of Earnings
Iran war's Inflationary impact is the key risk to Asia insurers: Swiss Re
Paul Murray, CEO of Life and Health Reinsurance at Swiss Re, says inflation risks in Asia due to the Iran war and rising energy prices are a key concern for the insurance sector in the region. He also...
Swiss Re AG Transcript: AGM 2026
Record net income and strong capital position enabled a higher dividend and share buyback. Strategic focus on core business, technology, and sustainability was reaffirmed, with all board proposals and compensation motions approved. Shareholders raised climate and governance concerns.
Swiss Re AG Slides: Corporate presentation
Swiss Re AG has posted slides in relation to its latest quarterly earnings report, which was published on March 16, 2026.
Swiss Re price target lowered to CHF 118 from CHF 120 at Morgan Stanley
Morgan Stanley analyst Hadley Cohen lowered the firm’s price target on Swiss Re (SSREY) to CHF 118 from CHF 120 and keeps an Underweight rating on the shares. Published first…
Swiss Re price target lowered to CHF 145 from CHF 155 at JPMorgan
JPMorgan analyst Kamran Hossain lowered the firm’s price target on Swiss Re (SSREY) to CHF 145 from CHF 155 and keeps a Neutral rating on the shares. Published first on…
Swiss Re AG Earnings Call Transcript: Q4 2025
Record net income of $4.8B and 20% ROE in 2025, with strong P&C and Corporate Solutions performance, robust capital returns, and a focus on resilience. Outlook for 2026 targets $4.5B net income and continued cost reductions.
Swiss Re AG Annual report: Q4 2025
Swiss Re AG has published its Q4 2025 annual report on February 27, 2026.
Swiss Re AG Earnings release: Q4 2025
Swiss Re AG released its Q4 2025 earnings on February 27, 2026, summarizing the period's financial results.
Swiss Re AG Slides: Q4 2025
Swiss Re AG has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 27, 2026.
Swiss Re AG Earnings Call Transcript: Q4 2025
Record net income of $4.8B in 2025 exceeded targets, driven by strong underwriting, cost savings, and portfolio resilience. Shareholder returns rise with a $1.5B buyback and 9% dividend hike, while 2026 guidance reflects normalized catastrophe assumptions.
Swiss Re AG Earnings release: Q4 2025
Swiss Re AG released its Q4 2025 earnings on February 27, 2026, summarizing the period's financial results.
Swiss Re AG Slides: Q4 2025
Swiss Re AG has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 27, 2026.
Swiss Re Profit Slips on Lower Revenue
The reinsurer posted a decline in fourth-quarter net profit on a softer top line, falling to $717 million from the $1.05 billion reported the year prior.
Swiss Re downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs downgraded Swiss Re (SSREY) to Sell from Neutral with a CHF 121 price target The firm adjusted ratings in European insurance, saying that although near-term earnings risks are…
Swiss Re price target lowered to CHF 120 from CHF 130 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Swiss Re (SSREY) to CHF 120 from CHF 130 and keeps an Underweight rating on the shares.
Swiss Re downgraded to Neutral from Buy at UBS
UBS downgraded Swiss Re (SSREY) to Neutral from Buy with a price target of CHF 135, down from CHF 150. The firm thinks investors need time and data to ease…